ERBB2 and gastric cancer: These findings fit well with a significant association reported between the overexpression of FASN and HER2 at the clinical level in a cohort of GC patients where those with concordant expression patterns of both proteins in GC tissues had a worse prognosis potentially due to their simultaneous and reciprocal activation [23].